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358a Monday, February 22, 2010digestion studies indicate that cTnI Delbp529AA is degraded at a faster rate
than wild-type cTnI. These results suggest that the poor prognosis of patients
carrying these RCM-linked mutants is due to protein dysfunction at multiple
levels and suggest possible mechanisms of RCM pathology.1851-Pos
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Protein kinase C (PKC) isoforms have been shown to play an important role in
the development of heart failure. Most research performed on PKCa has been
done in rodents and direct evidence in human heart failure is limited. Our pre-
vious study showed a decrease in Ca2þ-sensitivity in failing tissue upon PKCa
treatment of cardiomyocytes via phosphorylation of cardiac troponin I (cTnI),
cardiac troponin T (cTnT) and myosin binding protein C (cMyBP-C). This
study aims to determine the targets of PKCa on cTnI and cTnT. Western im-
munoblotting revealed that PKCa is less abundant but more active in failing
compared to donor tissue. PKCa treatment of donor and failing tissue was
able to phosphorylate Thr-143, which is a known PKCa site on cTnI, but en-
dogenous phosphorylation levels were very low. LC-MS analysis of purified
human recombinant cTn complex incubated with PKCa identified two novel
phosphorylation sites, Ser-199 located on cTnI and Ser-189 on cTnT. Both sites
are located in conserved regions on cTnI and cTnT. The PKA sites Ser23/24 on
cTnI are phosphorylated by PKCa in purified human recombinant cTn com-
plex, but there is no cross phosphorylation in donor and failing tissue. In con-
clusion, endogenous Thr-143 phosphorylation is low, which makes its involve-
ment in heart failure unlikely. Exogenous PKCa phosphorylation of Thr-143
and Ser-199 on cTnI and Ser-189 on cTnT could possibly explain the decrease
in Ca2þ-sensitivity observed and further research on the site-specific effects is
warranted.1852-Pos
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Troponin T (TnT) and troponin I (TnI) are two subunits of the troponin com-
plex. We previously found a single amino acid substitution in the TnT-binding
helix of cardiac TnI (cTnI) in wild turkey hearts that expressed abnormally
spliced myopathic cardiac TnT (cTnT) (Biesiadecki et al., JBC 279:13825-
32, 2004). To test the potential role of this cTnI modification in rescuing
a cTnT abnormality, we developed transgenic mice expressing the cTnI var-
iant (K118C) with or without a deletion of endogenous cTnI gene to mimic
homozygote and heterozygote wild turkeys. Double and triple transgenic
mice were created to combine the cTnI-K118C allele with an allele encoding
the abnormally spliced cTnT (exon 7 deletion). Functional analysis in ex vivo
working hearts found that cTnI-K118C had no destructive effect on cardiac
muscle and baseline heart function but was able to rescue the decreases in car-
diac function caused by cTnT exon 7 deletion. Further characterizations
showed that cTnI-K118C significantly blunted the inotropic response of car-
diac muscle to b-adrenergic stimulation whereas the PKA-dependent phos-
phorylation of cTnI was unchanged. These data indicate that TnI-TnT interac-
tion is a critical link in Ca2þ signaling and b-adrenergic regulation of
myocardial contraction, providing a novel target for the treatment of heart
failure.
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An alpha-helical region of cardiac troponin T, cH2(T), is centrally positioned
in the core domain of the troponin complex (Takeda et al., Nature 2003
vol.424(6944):p35-41). cH2(T)-troponin I and cH2(T)-troponin C interactions
have been illustrated through biochemical studies and visualized in the crystal
structure of the core domain of human cardiac troponin, suggesting an impor-tant regulatory role for cH2(T). However, little is known about how the car-
diac-specific structure of cH2(T) relates to cardiac-specific contractile func-
tion. To better understand the functional significance of cH2(T), we created
a chimeric rat cardiac troponin T (TnT) in which cH2(T) was replaced by
the corresponding helical region of rat slow skeletal TnT and studied how re-
placement of native TnT with chimeric TnT affected contractile function of
rat cardiac muscle. We measured isometric force, ATPase activity, and
length-dependent contractile dynamics in detergent skinned papillary muscle
bundles reconstituted with either wild-type or chimeric TnT, held at either sar-
comere length (SL) 2.0 mm or 2.2 mm. Preliminary studies suggest that the SL
dependence of Ca2þ-activated maximal force production and tension cost was
depressed in bundles containing chimeric TnT. For example, bundles contain-
ing the chimeric TnT showed an 8.4% decrease in force production when SL
was decreased from 2.2 mm to 2.0 mm, whereas bundles containing the wild-
type TnT showed a 43.9% decrease in force production. In addition, length-
dependent contractile dynamics were significantly altered in bundles contain-
ing the chimeric TnT. For example, the length-dependent rate constant of
crossbridge recruitment was slower, and the rate constant of crossbridge de-
tachment was faster in bundles containing the chimeric TnT. Thus, our data
suggest that cH2(T) plays a role in cardiac-specific length-mediated myofila-
ment activation, an important mechanism underlying the Frank-Starling rela-
tionship.
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Familial Hypertrophic Cardiomyopathy (FHC) is a primary cardiac muscle
disorder and a common cause of sudden cardiac death among young people
in the field. The majority of disease-causing mutations in the thin filament
protein hcTnT are found within the TNT1 domain. This domain has not
been crystallized and its structural details are poorly defined, limiting our
ability to understand the mechanism of disease for these mutations. A highly
charged region is found at the C-terminal end of TNT1
(158-RREEEENRR-166) in which this highly alpha helical domain may un-
wind to create a flexible hinge that is necessary for normal function. We
aim to determine the structural details and function of this region using
SDSL-EPR and regulated in vitro motility (R-IVM) assays. The purpose of
our R-IVM experiments is two-fold: to functionally analyze our spin labeled
proteins and to gain insight into the function of TNT1 in the presence of cys-
teine substitutions. R-IVM data shows a progressive increase in the severity of
the functional effects of cysteine substitution and spin labeling across the pu-
tative hinge region, suggesting that this region is dynamically important and
may be making critical interactions with other components of the sarcomere.
CW-EPR spectra of spin labeled hcTnT in Troponin ternary complexes show
an increase in spin label mobility from residue 153 to 157 and 177, consistent
with a decrease in alpha helical character across the putative hinge region.
Preliminary doubly labeled CW-EPR experiments show that interspin distance
between hcTnT residues 157 and 177 exceed 25A. Interspin distance measure-
ments using doubly labeled hcTnT will further elucidate the secondary and
tertiary structure of this region. Additional spin label pairs are currently being
investigated using both CW-EPR and DEER techniques to determine the
structural details of this important region.
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Tropomyosin-kappa (TPM1k), a novel TM isoform, is exclusively expressed
in the human heart. Alternative splicing of the a-TM gene generates TPM1k,
in which the skeletal muscle exon 2b is replaced by the smooth muscle exon
2a. We previously reported that TPM1k expression was increased in the
hearts of patients with chronic dilated cardiomyopathy (DCM). To under-
stand how the TPM1k isoform affects cardiac dynamics, we generated trans-
genic (TG) mice expressing TPM1k in the myocardium. Most of the native
TM (90%) is replaced by TPM1k. In situ cardiac dynamics were determined
by echocardiographic analysis. Results demonstrated that the TG hearts ex-
hibited a diastolic dysfunction associated with a dilation of the left ventricle
compared with the non transgenic (NTG) controls. We also compared force-
pCa relations in detergent extracted (skinned) fiber bundles isolated from
NTG and TG-TPM1k hearts at sarcomere lengths (SL) 1.9 mm and 2.3mm.
Our data demonstrated a significant decrease in the Ca2þ sensitivity of the
